Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.19.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]    
Net operating loss $ 7,155,358 $ 4,309,231
Non-deductible interest expense 247,938
Debt issue costs 426,817
Stock-based compensation expense 586,164 201,950
Patent licenses 15,826 17,077
Research and development tax credit carryforward 91,535 194,345
Accrued expenses 12,123 8,981
Section 195 deferred start-up costs 24,286 26,445
Deferred tax assets 8,560,047 4,758,029
Discount on debt (1,014,484)
Depreciation (2,766) (2,904)
Deferred tax liabilities (2,766) (1,017,388)
Deferred tax assets, net of deferred tax liabilities 8,557,281 3,740,641
Less: valuation allowance (8,557,281) (3,740,641)
Deferred tax assets, net after valuation allowance